Nanoviricides Inc (NNVC)
1.80
-0.46
(-20.35%)
USD |
NYAM |
May 15, 14:39
Nanoviricides Cash and Short Term Investments (Quarterly): 5.245M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.245M |
| September 30, 2023 | 6.970M |
| June 30, 2023 | 8.150M |
| March 31, 2023 | 9.651M |
| December 31, 2022 | 11.45M |
| September 30, 2022 | 12.92M |
| June 30, 2022 | 14.07M |
| March 31, 2022 | 15.57M |
| December 31, 2021 | 17.34M |
| September 30, 2021 | 19.70M |
| June 30, 2021 | 20.52M |
| March 31, 2021 | 22.90M |
| December 31, 2020 | 18.39M |
| September 30, 2020 | 21.79M |
| June 30, 2020 | 13.71M |
| March 31, 2020 | 6.106M |
| December 31, 2019 | 0.7076M |
| September 30, 2019 | 0.875M |
| June 30, 2019 | 2.555M |
| March 31, 2019 | 4.237M |
| December 31, 2018 | 3.904M |
| September 30, 2018 | 6.082M |
| June 30, 2018 | 7.082M |
| March 31, 2018 | 10.62M |
| December 31, 2017 | 12.05M |
| Date | Value |
|---|---|
| September 30, 2017 | 13.51M |
| June 30, 2017 | 15.10M |
| March 31, 2017 | 16.16M |
| December 31, 2016 | 19.30M |
| September 30, 2016 | 21.91M |
| June 30, 2016 | 24.16M |
| March 31, 2016 | 25.60M |
| December 31, 2015 | 28.24M |
| September 30, 2015 | 29.48M |
| June 30, 2015 | 31.47M |
| March 31, 2015 | 33.92M |
| December 31, 2014 | 35.26M |
| September 30, 2014 | 41.12M |
| June 30, 2014 | 36.70M |
| March 31, 2014 | 33.27M |
| December 31, 2013 | 16.95M |
| September 30, 2013 | 19.20M |
| June 30, 2013 | 13.92M |
| March 31, 2013 | 15.46M |
| December 31, 2012 | 13.88M |
| September 30, 2012 | 12.93M |
| June 30, 2012 | 14.28M |
| March 31, 2012 | 12.98M |
| December 31, 2011 | 12.10M |
| September 30, 2011 | 10.88M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.7076M
Minimum
Dec 2019
22.90M
Maximum
Mar 2021
12.03M
Average
12.92M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 299.35M |
| Enanta Pharmaceuticals Inc | 300.31M |
| GlycoMimetics Inc | 31.28M |
| FibroGen Inc | 177.60M |
| Corvus Pharmaceuticals Inc | 22.13M |